What is Tensordyne worth?
$510.0Mlast known valuation
Tensordyne last raised $35.0M in its Series C1 (Jul 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for Tensordyne
Create free account
No card required
Valuation timeline
3 marks · May 2019 – Feb 2024Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2025 | Series C1 | $35.0M | ▮ | ▮ |
| Feb 2024 | Series C | $100.0M | ▮ | ▮ |
| Feb 2021 | Series B | $48.9M | ▮ | ▮ |
| May 2019 | Series A | $25.0M | ▮ | ▮ |
How Tensordyne's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Tensordyne, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Tensordyne worth?
- Tensordyne's last known valuation is $510.0M.
- How much has Tensordyne raised?
- Tensordyne has raised $208.9M in total funding across 4 recorded rounds.
- When did Tensordyne last raise?
- Tensordyne last raised in Jul 2025 (Series C1), raising $35.0M.
Live secondary market
offer $45.001 active listings
Indicative levels observed on the secondary market. Private Market View is a data platform — it does not execute transactions or take buy or sell interest.